2015 Q1 Form 10-Q Financial Statement
#000114420415030769 Filed on May 14, 2015
Income Statement
| Concept | 2015 Q1 | 2014 Q1 |
|---|---|---|
| Revenue | $67.00K | $0.00 |
| YoY Change | ||
| Cost Of Revenue | $297.0K | $421.0K |
| YoY Change | -29.45% | |
| Gross Profit | -$230.0K | -$421.0K |
| YoY Change | -45.37% | |
| Gross Profit Margin | -343.28% | |
| Selling, General & Admin | $660.0K | $1.140M |
| YoY Change | -42.11% | -43.28% |
| % of Gross Profit | ||
| Research & Development | $883.0K | $1.107M |
| YoY Change | -20.23% | 64.0% |
| % of Gross Profit | ||
| Depreciation & Amortization | $79.00K | $198.0K |
| YoY Change | -60.1% | 69.23% |
| % of Gross Profit | ||
| Operating Expenses | $1.547M | $2.247M |
| YoY Change | -31.15% | 232.89% |
| Operating Profit | -$1.777M | -$2.668M |
| YoY Change | -33.4% | -13.26% |
| Interest Expense | $140.0K | $140.0K |
| YoY Change | 0.0% | -106.51% |
| % of Operating Profit | ||
| Other Income/Expense, Net | $139.0K | -$316.0K |
| YoY Change | -143.99% | 2006.67% |
| Pretax Income | -$1.640M | -$2.980M |
| YoY Change | -44.97% | -43.02% |
| Income Tax | $0.00 | |
| % Of Pretax Income | ||
| Net Earnings | -$1.638M | -$2.984M |
| YoY Change | -45.11% | -42.91% |
| Net Earnings / Revenue | -2444.78% | |
| Basic Earnings Per Share | -$0.14 | |
| Diluted Earnings Per Share | -$27.33M | -$0.14 |
| COMMON SHARES | ||
| Basic Shares Outstanding | 27.92M shares | 21.27B shares |
| Diluted Shares Outstanding | 21.42M shares |
Balance Sheet
| Concept | 2015 Q1 | 2014 Q1 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $1.900M | $4.000M |
| YoY Change | -52.5% | 1233.33% |
| Cash & Equivalents | $1.855M | $3.812M |
| Short-Term Investments | $100.0K | $200.0K |
| Other Short-Term Assets | $0.00 | $600.0K |
| YoY Change | -100.0% | |
| Inventory | $231.0K | |
| Prepaid Expenses | ||
| Receivables | $0.00 | |
| Other Receivables | $300.0K | |
| Total Short-Term Assets | $2.449M | $4.600M |
| YoY Change | -46.76% | 557.14% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $935.0K | $1.100M |
| YoY Change | -15.0% | -15.38% |
| Goodwill | ||
| YoY Change | ||
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | ||
| YoY Change | ||
| Other Assets | $0.00 | $0.00 |
| YoY Change | ||
| Total Long-Term Assets | $975.0K | $1.100M |
| YoY Change | -11.36% | -21.43% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $2.449M | $4.600M |
| Total Long-Term Assets | $975.0K | $1.100M |
| Total Assets | $3.424M | $5.700M |
| YoY Change | -39.93% | 171.43% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $800.0K | $500.0K |
| YoY Change | 60.0% | -28.57% |
| Accrued Expenses | ||
| YoY Change | ||
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | ||
| YoY Change | ||
| Total Short-Term Liabilities | $1.666M | $1.217M |
| YoY Change | 36.89% | 1.42% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $2.700M | $0.00 |
| YoY Change | ||
| Other Long-Term Liabilities | $3.900M | $5.800M |
| YoY Change | -32.76% | 16.0% |
| Total Long-Term Liabilities | $6.600M | $5.800M |
| YoY Change | 13.79% | 16.0% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $1.666M | $1.217M |
| Total Long-Term Liabilities | $6.600M | $5.800M |
| Total Liabilities | $8.200M | $7.000M |
| YoY Change | 17.14% | 14.75% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | -$37.70M | |
| YoY Change | ||
| Common Stock | $3.000K | |
| YoY Change | ||
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | -$4.750M | -$1.300M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $3.424M | $5.700M |
| YoY Change | -39.93% | 171.43% |
Cashflow Statement
| Concept | 2015 Q1 | 2014 Q1 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$1.638M | -$2.984M |
| YoY Change | -45.11% | -42.91% |
| Depreciation, Depletion And Amortization | $79.00K | $198.0K |
| YoY Change | -60.1% | 69.23% |
| Cash From Operating Activities | -$1.530M | -$2.340M |
| YoY Change | -34.62% | 141.24% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | $36.00K | $116.0K |
| YoY Change | -68.97% | -125.22% |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | $10.00K | $0.00 |
| YoY Change | ||
| Cash From Investing Activities | -$30.00K | -$120.0K |
| YoY Change | -75.0% | -73.91% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | ||
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | 1.960M | 4.000M |
| YoY Change | -51.0% | 700.0% |
| NET CHANGE | ||
| Cash From Operating Activities | -1.530M | -2.340M |
| Cash From Investing Activities | -30.00K | -120.0K |
| Cash From Financing Activities | 1.960M | 4.000M |
| Net Change In Cash | 400.0K | 1.540M |
| YoY Change | -74.03% | -265.59% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$1.530M | -$2.340M |
| Capital Expenditures | $36.00K | $116.0K |
| Free Cash Flow | -$1.566M | -$2.456M |
| YoY Change | -36.24% | 381.57% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2014Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2015Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1855000 | USD |
| CY2014Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1453000 | USD |
| CY2015Q1 | us-gaap |
Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
|
13000 | USD |
| CY2014Q4 | us-gaap |
Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
|
0 | USD |
| CY2015Q1 | us-gaap |
Short Term Investments
ShortTermInvestments
|
68000 | USD |
| CY2014Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
83000 | USD |
| CY2015Q1 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
260000 | USD |
| CY2014Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
286000 | USD |
| CY2015Q1 | us-gaap |
Assets Current
AssetsCurrent
|
2449000 | USD |
| CY2014Q4 | us-gaap |
Assets Current
AssetsCurrent
|
2056000 | USD |
| CY2015Q1 | us-gaap |
Deposits Assets Noncurrent
DepositsAssetsNoncurrent
|
40000 | USD |
| CY2014Q4 | us-gaap |
Deposits Assets Noncurrent
DepositsAssetsNoncurrent
|
47000 | USD |
| CY2015Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
935000 | USD |
| CY2014Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
978000 | USD |
| CY2015Q1 | us-gaap |
Assets
Assets
|
3424000 | USD |
| CY2014Q4 | us-gaap |
Assets
Assets
|
3081000 | USD |
| CY2015Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2015Q1 | us-gaap |
Accounts Payable Trade Current
AccountsPayableTradeCurrent
|
844000 | USD |
| CY2014Q4 | us-gaap |
Accounts Payable Trade Current
AccountsPayableTradeCurrent
|
708000 | USD |
| CY2015Q1 | us-gaap |
Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
|
766000 | USD |
| CY2014Q4 | us-gaap |
Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
|
884000 | USD |
| CY2015Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1666000 | USD |
| CY2015Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
30108131 | shares |
| CY2015Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001533998 | |
| CY2015Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
| CY2015Q1 | dei |
Trading Symbol
TradingSymbol
|
DRIO | |
| CY2015Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Smaller Reporting Company | |
| CY2015Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
LabStyle Innovations Corp. | |
| CY2015Q1 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
145000 | USD |
| CY2014Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-2337000 | USD |
| CY2015Q1 | drio |
Increase Decrease In Accounts Receivables And Prepaid Expense
IncreaseDecreaseInAccountsReceivablesAndPrepaidExpense
|
-22000 | USD |
| CY2014 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
7000 | USD |
| CY2015Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
883000 | USD |
| CY2015Q1 | us-gaap |
Marketing And Advertising Expense
MarketingAndAdvertisingExpense
|
252000 | USD |
| CY2015Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
1547000 | USD |
| CY2014Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1616000 | USD |
| CY2015Q1 | us-gaap |
Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
|
3853000 | USD |
| CY2014Q4 | us-gaap |
Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
|
4003000 | USD |
| CY2015Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
3000 | USD |
| CY2014Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
2000 | USD |
| CY2015Q1 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
| CY2014Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
| CY2015Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
32943000 | USD |
| CY2014Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
30761000 | USD |
| CY2015Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-37696000 | USD |
| CY2014Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-36058000 | USD |
| CY2015Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-4750000 | USD |
| CY2014Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-5295000 | USD |
| CY2015Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
3424000 | USD |
| CY2014Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
3081000 | USD |
| CY2015Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2014Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2015Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
80000000 | shares |
| CY2014Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
80000000 | shares |
| CY2015Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
27917266 | shares |
| CY2014Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
16233430 | shares |
| CY2015Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
27917266 | shares |
| CY2014Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
16233430 | shares |
| CY2015Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
| CY2014Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
| CY2015Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
4940000 | shares |
| CY2014Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
4940000 | shares |
| CY2015Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2014Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2015Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2014Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2015Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1777000 | USD |
| CY2015Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-1525000 | USD |
| CY2014Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1107000 | USD |
| CY2014Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2668000 | USD |
| CY2014Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-458000 | USD |
| CY2015Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-11000 | USD |
| CY2014Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-316000 | USD |
| CY2015Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
139000 | USD |
| CY2014Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2984000 | USD |
| CY2015Q1 | us-gaap |
Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
|
125000 | USD |
| CY2014Q1 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
448000 | USD |
| CY2015Q1 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
0 | USD |
| CY2014Q1 | us-gaap |
Depreciation
Depreciation
|
198000 | USD |
| CY2015Q1 | us-gaap |
Depreciation
Depreciation
|
79000 | USD |
| CY2014Q1 | drio |
Increase Decrease In Accounts Receivables And Prepaid Expense
IncreaseDecreaseInAccountsReceivablesAndPrepaidExpense
|
73000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
-242000 | USD |
| CY2015Q1 | us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
-118000 | USD |
| CY2015Q1 | us-gaap |
Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
|
13000 | USD |
| CY2015Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1638000 | USD |
| CY2013Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-86000 | USD |
| CY2014 | drio |
Stock Issued During Period Value New Issues February2014
StockIssuedDuringPeriodValueNewIssuesFebruary2014
|
1013000 | USD |
| CY2015Q1 | drio |
Stock Issued During Period Value New Issues April And May2013
StockIssuedDuringPeriodValueNewIssuesAprilAndMay2013
|
1956000 | USD |
| CY2014 | drio |
Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
|
352000 | USD |
| CY2015Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
0 | USD |
| CY2014 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
1692000 | USD |
| CY2015Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
125000 | USD |
| CY2014 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-12877000 | USD |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
1317400 | shares |
| CY2015Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
0 | shares |
| CY2015Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
6000 | shares |
| CY2015Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
97000 | shares |
| CY2015Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
86350 | shares |
| CY2015Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
1128050 | shares |
| CY2015Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
1104150 | shares |
| CY2015Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
930050 | shares |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
6.59 | |
| CY2015Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0 | |
| CY2015Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0.01 | |
| CY2015Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
5.83 | |
| CY2015Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
3.07 | |
| CY2015Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
6.62 | |
| CY2015Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
6.63 | |
| CY2015Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
6.80 | |
| CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P6Y11M23D | |
| CY2015Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P7Y2M8D | |
| CY2015Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P7Y1M24D | |
| CY2015Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P6Y9M7D | |
| CY2014Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
8000 | USD |
| CY2015Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
12000 | USD |
| CY2015Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
12000 | USD |
| CY2015Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
12000 | USD |
| CY2014Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
509000 | USD |
| CY2015Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
125000 | USD |
| CY2015Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
385000 | USD |
| CY2015Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P6M18D | |
| CY2014 | drio |
Issuance Of Common Stock In February And March2012
IssuanceOfCommonStockInFebruaryAndMarch2012
|
2.75 | |
| CY2015Q1 | drio |
Issuance Of Common Stock And Warrants In February And June2013
IssuanceOfCommonStockAndWarrantsInFebruaryAndJune2013
|
0.18 | |
| CY2014Q1 | us-gaap |
Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
|
509000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
-51000 | USD |
| CY2014Q1 | us-gaap |
Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
|
0 | USD |
| CY2014Q1 | us-gaap |
Payments To Acquire Leases Held For Investment
PaymentsToAcquireLeasesHeldForInvestment
|
0 | USD |
| CY2015Q1 | us-gaap |
Payments To Acquire Leases Held For Investment
PaymentsToAcquireLeasesHeldForInvestment
|
-7000 | USD |
| CY2014Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
116000 | USD |
| CY2015Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
36000 | USD |
| CY2014Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-116000 | USD |
| CY2015Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-29000 | USD |
| CY2014Q1 | drio |
Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
|
3813000 | USD |
| CY2015Q1 | drio |
Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
|
1956000 | USD |
| CY2014Q1 | drio |
Proceeds From Stock Options And Warrants Exercised
ProceedsFromStockOptionsAndWarrantsExercised
|
189000 | USD |
| CY2015Q1 | drio |
Proceeds From Stock Options And Warrants Exercised
ProceedsFromStockOptionsAndWarrantsExercised
|
0 | USD |
| CY2014Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
4002000 | USD |
| CY2015Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
1956000 | USD |
| CY2014Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
1549000 | USD |
| CY2015Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
402000 | USD |
| CY2013Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2263000 | USD |
| CY2014Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
3812000 | USD |
| CY2014Q1 | us-gaap |
Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
|
4000 | USD |
| CY2015Q1 | us-gaap |
Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
|
29000 | USD |
| CY2014Q1 | drio |
Conversionofwarantliabilitytocommonstock
Conversionofwarantliabilitytocommonstock
|
9000 | USD |
| CY2015Q1 | drio |
Conversionofwarantliabilitytocommonstock
Conversionofwarantliabilitytocommonstock
|
0 | USD |
| CY2014Q1 | us-gaap |
Revenues
Revenues
|
0 | USD |
| CY2015Q1 | us-gaap |
Revenues
Revenues
|
67000 | USD |
| CY2014Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
421000 | USD |
| CY2015Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
297000 | USD |
| CY2015Q1 | us-gaap |
Inventory Net
InventoryNet
|
231000 | USD |
| CY2014Q4 | us-gaap |
Inventory Net
InventoryNet
|
234000 | USD |
| CY2015Q1 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
2655000 | USD |
| CY2014Q4 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
2757000 | USD |
| CY2014Q1 | us-gaap |
Gross Profit
GrossProfit
|
-421000 | USD |
| CY2015Q1 | us-gaap |
Gross Profit
GrossProfit
|
-230000 | USD |
| CY2014Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
45000000 | shares |
| CY2014Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
2247000 | USD |
| CY2014Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-142000 | USD |
| CY2015Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-150000 | USD |
| CY2015Q1 | us-gaap |
Revenue Recognition Software
RevenueRecognitionSoftware
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 56.7pt; size: 8.5in 11.0in" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <table style="LINE-HEIGHT: 115%; WIDTH: 100%; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 58.5pt; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="78"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27pt; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="36"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>a.</font></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt" align="justify"><font style="FONT-SIZE: 10pt">Revenue recognition:</font></div> </td> </tr> </table> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 85.5pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt">Revenues from product sales are recognized in accordance with ASC 605-10 "Revenue Recognition", when delivery has occurred, persuasive evidence of an agreement exists, the vendor’s fee is fixed or determinable, no further obligation exists and collectability is probable.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 112.5pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 85.05pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt">The Company derives revenues from the sale of its Dario™ Smart Meter and its related device-specific disposables test strip cartridges and lancets through independent distributers or directly to end users. The Dario™ software application is offered for a free download and the Company does not obtain a recurring hosting commitment towards the end users relating specifically to the application.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt 85.5pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 85.05pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt">The Company generally has a standard contract with its distributors. According to the agreements, all sales to distributors are final, no rights of return or price protection right is granted to such distributors and the Company is not a party of the agreements between distributors and their customers. In certain arrangement, the Company has granted to the distributors limited rights of return on unsold products.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 85.05pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 85.05pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt">Through March 31, 2015, product sales to distributors are recognized as revenues upon receipt of payment unless the distributer has a right of return on unsold products. The Company will apply this policy until it will have sufficient historical experience with each distributor in order to conclude that fee is fixed or determinable and collectability is probable.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 85.05pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 85.5pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt">The Company also generates revenues from arrangements with health care providers which include supply of Dario™ Smart Meters and software platform that requires certain customization followed by monthly service, support and maintenance.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px 0px 0px 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">When a sales arrangement contains multiple elements, such as software and non-software components, the Company allocates revenue to each element based on a selling price hierarchy as required according to ASC 605-25, "Multiple-Element Arrangements". The selling price for a deliverable is based on its Vendor Specific Objective Evidence (“VSOE”), if available, third party evidence ("TPE") if VSOE is not available, or estimated selling price ("ESP") if neither VSOE nor TPE is available. The best estimate of selling price is established considering several internal factors including, but not limited to, historical sales, pricing practices and geographies in which the Company offers its products. The determination of ESP is judgmental.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 85.05pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 85.05pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt">Revenues from software components in sales arrangement contains multiple elements are recognized when all criteria outlined in ASC 985-605, "Software Revenue Recognition" ("ASC 985-605"), are met. Revenue from services is recognized when persuasive evidence of an arrangement exists, delivery of the product has occurred or the services have been rendered, the fee is fixed or determinable and collectability is probable.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 85.05pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px 0px 0px 85.05pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">For multiple element arrangements within ASC 985-605, revenues are allocated to the different elements in the arrangement under the "residual method" when VSOE of fair value exist for all undelivered elements and no VSOE exists for the delivered elements. Under the residual method, at the outset of the arrangement with the customer, the fair value of the undelivered elements is deferred and the remaining portion of the arrangement fee is allocated to the delivered elements and is recognized as revenue when the basic criteria in ASC 985-605 have been met. Any discount in the arrangement is allocated to the delivered element.</div> <font style="FONT-SIZE: 10pt"> </font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 85.05pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt">Since VSOE does not exist for undelivered elements, revenues are recognized as one unit of accounting, on a straight-line basis over the term of the last deliverable based on ASC 605-15, “Products” and ASC 985-605.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 85.05pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt">Deferred revenues include advances and payments received from customers, for which revenue has not yet been recognized.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 28.35pt; MARGIN: 0in 0in 0pt 56.7pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt">The Company’s shipping and handling costs are included in cost of revenues.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2015Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
|
-150000 | USD |
| CY2015Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
3853000 | USD |
| CY2014Q1 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
0 | USD |
| CY2015Q1 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
102000 | USD |
| CY2015Q1 | us-gaap |
Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
|
189000 | USD |
| CY2014Q4 | us-gaap |
Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
|
68000 | USD |
| CY2015Q1 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
42000 | USD |
| CY2014Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
166000 | USD |
| CY2014Q1 | drio |
Bank Charges
BankCharges
|
5000 | USD |
| CY2015Q1 | drio |
Bank Charges
BankCharges
|
4000 | USD |
| CY2014Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-5000 | USD |
| CY2015Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-7000 | USD |
| CY2014Q1 | us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
448000 | USD |
| CY2015Q1 | us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
0 | USD |
| CY2014 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
0 | USD |
| CY2014 | drio |
Deemed Dividend Related To Exchange Agreement Adjustment
DeemedDividendRelatedToExchangeAgreementAdjustment
|
0 | USD |
| CY2014 | drio |
Stock Issued During Period Value Upon Exchange Agreement
StockIssuedDuringPeriodValueUponExchangeAgreement
|
4558000 | USD |
| CY2014 | drio |
Deemed Dividend Related To Preferred Stock
DeemedDividendRelatedToPreferredStock
|
0 | USD |
| CY2014 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
46000 | USD |
| CY2015Q1 | us-gaap |
Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
|
1552 | shares |
| CY2014Q1 | drio |
Revaluation Of Warrant Income Expenses
RevaluationOfWarrantIncomeExpenses
|
142000 | USD |
| CY2015Q1 | drio |
Revaluation Of Warrant Income Expenses
RevaluationOfWarrantIncomeExpenses
|
150000 | USD |
| CY2015Q1 | us-gaap |
Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
|
22000 | USD |
| CY2014Q4 | us-gaap |
Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
|
0 | USD |
| CY2015Q1 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
56000 | USD |
| CY2014Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
24000 | USD |
| CY2015Q1 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 28.35pt; MARGIN: 0in 0in 0pt 56.7pt; size: 8.5in 11.0in" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <table style="LINE-HEIGHT: 115%; WIDTH: 100%; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 58.5pt; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="78"> <div style="CLEAR:both;CLEAR: both"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 27pt; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="36"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <font style="FONT-SIZE: 10pt">b.</font></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt" align="justify"><font style="FONT-SIZE: 10pt"> Reclassification:</font></div> </td> </tr> </table> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 85.5pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 85.05pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt">Certain amounts that are related to the Company's ramp up of manufacturing costs were classified as part of sales and marketing costs in the consolidated statements of comprehensive loss in the corresponding period ended March 31, 2014 and therefore have been reclassified into cost of revenues in order to conform to the current period presentation.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2015Q1 | us-gaap |
Basis Of Accounting
BasisOfAccounting
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: -56.7pt; MARGIN: 0px 0px 0px 56.7pt; FONT: bold 10pt Times New Roman, Times, Serif"> NOTE 3:-       UNAUDITED INTERIM FINANCIAL STATEMENTS</div>   <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0px 0px 0px 56.9pt; FONT: 10pt Times New Roman, Times, Serif" align="justify">The accompanying unaudited interim consolidated financial statements as of March 31, 2015, have been prepared in accordance with U.S. generally accepted accounting principles and standards of the Public Company Accounting Oversight Board for interim financial information. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles in the United States for complete financial statements. In the opinion of management, the unaudited interim consolidated financial statements include all adjustments of a normal recurring nature necessary for a fair presentation of the Company's consolidated financial position as of March 31, 2015, and the Company's consolidated results of operations and the Company's consolidated cash flows for the three months ended March 31, 2015. Results for the three months ended March 31, 2015 are not necessarily indicative of the results that may be expected for the year ending December 31, 2015.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2014 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
1046000 | USD |
| CY2015Q1 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
62000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
|
0 | USD |
| CY2015Q1 | us-gaap |
Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
|
22000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
0 | USD |
| CY2015Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
32000 | USD |
| CY2014Q1 | us-gaap |
Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
|
0 | USD |
| CY2015Q1 | us-gaap |
Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
|
-13000 | USD |
| CY2014Q1 | us-gaap |
Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
|
67000 | USD |
| CY2015Q1 | us-gaap |
Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
|
0 | USD |
| CY2014Q4 | us-gaap |
Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
|
one-for-five | |
| CY2014Q1 | drio |
Preferred Stock Converted Into Common Stock At Ratio
PreferredStockConvertedIntoCommonStockAtRatio
|
ratio of 1 to 252 |
